(Press-News.org) A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma multiforme (GBM), the new drug helped significantly extend survival when used in combination with radiation therapy.
Recently published in the journal Clinical Cancer Research, the study provides the first preclinical evidence demonstrating that an ATM kinase inhibitor radiosensitizes gliomas. Gliomas are brain tumors that originate from glial cells, which provide support for nerve cells and help regulate the internal environment of the brain. ATM, or ataxia telangiectasia mutated, is an enzyme that helps repair DNA damage. The scientists used an experimental drug, KU-60019, to block the activation of ATM, which led to the enhanced destruction of the gliomas due to their reduced ability to repair the DNA damage caused by the radiation treatment. The new approach was particularly effective against gliomas that have a mutation in the p53 tumor suppressor gene, which accounts for approximately 30 percent of all glioma cases.
"Sadly, the average life expectancy of patients diagnosed with glioblastoma is just 12 to 15 months," says the study's lead researcher Kristoffer Valerie, Ph.D., co-leader of the Radiation Biology and Oncology research program and a professor in the Department of Radiation Oncology at VCU Massey Cancer Center. "By limiting the tumor's ability to combat DNA damage caused by treatments such as radiation, we are hopeful that we can enhance our ability to specifically target the glioma, prolong survival and reduce damage to surrounding brain tissue."
Currently, GBM is treated with surgery, followed by chemotherapy and radiation therapy. Potentially, ATM kinase inhibitors like the one used in this study could enhance the effectiveness of some other cancer treatments that kill tumor cells by damaging DNA. The scientists chose radiation therapy in this study since it is already standard care and can be delivered to brain tumors with extreme accuracy, minimizing damage to surrounding healthy tissue.
"If these findings hold up in early phase clinical trials, we expect patients with p53 mutant gliomas to respond well to this treatment while showing few side effects. Also, we anticipate that this same treatment strategy could be effective for other cancers that are treated with DNA-damaging chemotherapies," says Valerie. "We are encouraged by these early findings and will continue to move forward with our research. However, more studies are needed before we can proceed with testing this new therapy in humans."
This first, 'proof-of-principle' study is an important follow-up of a study published several years ago on KU-60019 by Valerie and his research team that demonstrated KU-60019's superior efficacy, specificity and potency on glioma cells as compared to a predecessor ATM inhibitor.
Valerie and his team are conducting additional studies examining the effects of KU-60019 and other ATM kinase inhibitors on gliomas, including studies that combine ATM kinase inhibitors with a type of drug known as a PARP inhibitor to increase the effectiveness of the treatment. PARP inhibitors block the action of poly ADP ribose polymerase (PARP), an enzyme that also aids in the repair of DNA damage. The researchers believe that combining an ATM kinase inhibitor with a PARP inhibitor may cause a condition referred to as "synthetic lethality," which arises when the functions of at least two interacting genes are simultaneously inhibited, which, in turn, leads to tumor cell death.
INFORMATION:
Valerie collaborated on this study with Sumitra Deb, Ph.D., a member of the Cancer Molecular Genetics research program at VCU Massey Cancer Center and professor in the Department of Biochemistry and Molecular Biology at VCU School of Medicine; Nitai D. Mukhopadhyay, M.Stat., Ph.D., a member of the Radiation Biology and Oncology research program at VCU Massey and assistant professor in the Department of Biostatistics at VCU School of Medicine; Laura Biddlestone-Thorpe, Muhammad Sajjad, Elizabeth Rosenberg, Jason M. Beckta, Nicholas C.K. Valerie, Mary Tokarz, Bret R. Adams, Alison F Wagner, Ashraf Khalil, Donna Gilfor and Sarah E. Golding, all from the Department of Radiation Oncology at VCU School of Medicine; David G. Temesi, Ph.D., Alan Lau, Ph.D., and Mark J. O'Connor, Ph.D., all from AstraZeneca; and Kevin S Choe, M.D., Ph.D., Luis F. Parada, Ph.D., and Sang Kyun Lim, Ph.D., all from the University of Texas Southwestern.
This study was supported by National Institutes of Health Grant R01NS064593 and National Cancer Institute Grants R21CA156995, T32CA113277, T32CA085159, T32CA085159 and F30CA171893. Additional support was provided by the American Brain Tumor Association and, in part, by funding from VCU Massey Cancer Center's NIH-NCI Cancer Center Support Grant P30 CA016059.
The full manuscript of this study is available online at: http://clincancerres.aacrjournals.org/content/early/2013/04/25/1078-0432.CCR-12-3408.abstract
New drug enhances radiation treatment for brain cancer in preclinical studies
2013-05-15
ELSE PRESS RELEASES FROM THIS DATE:
Using clay to grow bone
2013-05-15
Boston, MA – In new research published online May 13, 2013 in Advanced Materials, researchers from Brigham and Women's Hospital (BWH) are the first to report that synthetic silicate nanoplatelets (also known as layered clay) can induce stem cells to become bone cells without the need of additional bone-inducing factors. Synthetic silicates are made up of simple or complex salts of silicic acids, and have been used extensively for various commercial and industrial applications, such as food additives, glass and ceramic filler materials, and anti-caking agents.
Silicate ...
Newly described type of immune cell and T cells share similar path to maturity
2013-05-15
PHILADELPHIA — Labs around the world, and a core group at Penn, have been studying recently described populations of immune cells called innate lymphoid cells (ILCs). Some researchers liken them to foot soldiers that protect boundary tissues such as the skin, the lining of the lung, and the lining of the gut from microbial onslaught. They also have shown they play a role in inflammatory disease, when the body's immune system is too active.
In animal studies, group-2 innate lymphoid cells (ILC2s) confer immunity during a parasitic infection in mice and are also involved ...
Trying to be happier works when listening to upbeat music
2013-05-15
The song, "Get Happy," famously performed by Judy Garland, has encouraged people to improve their mood for decades. Recent research at the University of Missouri discovered that an individual can indeed successfully try to be happier, especially when cheery music aids the process. This research points to ways that people can actively improve their moods and corroborates earlier MU research.
"Our work provides support for what many people already do – listen to music to improve their moods," said lead author Yuna Ferguson, who performed the study while she was an MU doctoral ...
Male testosterone levels increase when victorious in competition against rivals, but not friends
2013-05-15
Sporting events can bring a community together, such as when the Louisville Cardinals won the NCAA championship and University of Louisville campus was filled with camaraderie. They also can fuel bitter rivalries, such as the long-standing animosity between the St. Louis Cardinals and the Chicago Cubs. A University of Missouri study has found that testosterone levels during group competition are modulated depending on the relationships among the competitors and may be related to the formation of alliances in warfare.
"One interesting thing about humans is that we are ...
What is the role of double-stranded RNA in antiviral host defense systems?
2013-05-15
New Rochelle, NY, May 14, 2013—Animals, insects, and plants use a variety of sensing mechanisms to detect invading pathogens such as viruses. One complex and effective antiviral defense system they share is based on recognition of double-stranded RNA (dsRNA), often produced when a virus invades a host cell. New information leading to a clearer understanding of the mechanisms underlying viral dsRNA sensing is presented in a comprehensive Review article published in Journal of Interferon & Cytokine Research, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. ...
Cardio and weight training reduces access to health care in seniors
2013-05-15
Forget apples – lifting weights and doing cardio can also keep the doctors away, according a new study by researchers at the University of British Columbia and Vancouver Coastal Health Research Institute.
The study, published today in the online journal PLOS ONE, followed 86 women, aged 70- to 80-years-old, who were randomly assigned to participate in weight training classes, outdoor walking classes, or balance and toning classes (such as yoga and pilates) for six months. All participants have mild cognitive impairment, a well-recognized risk factor for Alzheimer's disease ...
Nearly 50 percent increase in ICU admissions, new study says
2013-05-15
WASHINGTON, DC—A study released today by George Washington University School of Public Health and Health Services (SPHHS) researchers offers an in-depth look at hospitals nationwide and admissions to intensive care units (ICU). The study, published in the journal Academic Emergency Medicine, finds a sharp increase—nearly 50 percent—in ICU admissions coming from U.S. emergency departments.
"These findings suggest that emergency physicians are sending more patients on to the ICU," said SPHHS researcher and lead author Peter Mullins. "The increase might be the result of ...
NJIT computer scientist publishes new algorithm cluster to data mine health records
2013-05-15
The time may be fast approaching for researchers to take better advantage of the vast amount of valuable patient information available from U.S. electronic health records. Lian Duan, an NJIT computer scientist with an expertise in data mining, has done just that with the recent publication of "Adverse Drug Effect Detection," IEEE Journal of Biomedical and Health Informatics (March, 2013).
The article spotlights a new and promising way of using a combination of commonly used existing algorithms to root out more information about adverse drug reactions within electronic ...
Non-communicable diseases account for half of adult female deaths in rural Bangladesh
2013-05-15
While global attention has for decades been focused on reducing maternal mortality, population-based data on other causes of death among women of reproductive age has been virtually non-existent. A study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health found that non-communicable diseases accounted for 48 percent of 1,107 investigated female deaths in rural Bangladesh between 2002 and 2007. The findings lend urgency to review global health priorities to address neglected and potentially fatal non-communicable diseases affecting rural women ...
Penn research helps paint finer picture of massive 1700 earthquake
2013-05-15
In 1700, a massive earthquake struck the west coast of North America. Though it was powerful enough to cause a tsunami as far as Japan, a lack of local documentation has made studying this historic event challenging.
Now, researchers from the University of Pennsylvania have helped unlock this geological mystery using a fossil-based technique. Their work provides a finer-grained portrait of this earthquake and the changes in coastal land level it produced, enabling modelers to better prepare for future events.
Penn's team includes Benjamin Horton, associate professor ...